Propanc Biopharma Inc（PPCB）价格预测PPCBPropanc Biopharma Inc

Alphio's PPCB stock price prediction model matches the current Propanc Biopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.80 (-0.97%). The 1-week path is $1.88 (+3.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Propanc Biopharma Inc (PPCB) is not a good buy right now. The current price is $1.75, which is significantly down 98.78% year-to-date and 99.22% over the past year. The RSI is at 27.15, indicating that the stock is oversold, but the forward P/E ratio is 0, suggesting no earnings growth is expected in the near future. The main risk is the company's negative net income, which reached -$63,603,336 in Q3 2025, indicating ongoing financial struggles.

Propanc Biopharma Inc (PPCB) last closed at $1.8200001, gaining +4.00%. These facts feed the 1-day and 1-week PPCB price prediction above.